Compounds > dioscin
Page last updated: 2024-09-03

dioscin and Liver Cirrhosis

dioscin has been researched along with Liver Cirrhosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, X; Li, L; Peng, J; Qi, Y; Song, S; Sun, P; Tao, X; Xu, L; Xu, Y; Yin, L1
Han, X; Lin, Y; Liu, K; Peng, J; Qi, Y; Sun, H; Xu, L; Xu, Y; Yin, L; Zhang, X1
Han, X; Peng, J; Qi, Y; Xu, L; Xu, Y; Yin, L; Zhang, X1
Gu, L; Han, X; Peng, J; Qi, Y; Tao, X; Xu, L; Xu, Y; Yin, L1

Other Studies

4 other study(ies) available for dioscin and Liver Cirrhosis

ArticleYear
Dioscin, a potent ITGA5 inhibitor, reduces the synthesis of collagen against liver fibrosis: Insights from SILAC-based proteomics analysis.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2017, Volume: 107, Issue:Pt A

    Topics: Amino Acids; Animals; Collagen; Diosgenin; Humans; Integrin alpha5; Isotope Labeling; Liver Cirrhosis; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Proteomics; Rats; Signal Transduction

2017
Potent effects of dioscin against liver fibrosis.
    Scientific reports, 2015, Apr-08, Volume: 5

    Topics: Animals; Apoptosis; Cellular Senescence; Diosgenin; Extracellular Matrix; Hepatic Stellate Cells; Hepatocytes; Liver Cirrhosis; Male; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Oxidative Stress; Rats; Signal Transduction; Smad Proteins; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta; Wnt Signaling Pathway

2015
Quantitative chemical proteomics for investigating the biomarkers of dioscin against liver fibrosis caused by CCl4 in rats.
    Chemical communications (Cambridge, England), 2015, Jul-14, Volume: 51, Issue:55

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Diosgenin; Liver Cirrhosis; Male; Proteomics; Rats; Rats, Wistar

2015
Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway.
    Toxicology and applied pharmacology, 2016, Feb-01, Volume: 292

    Topics: Animals; Bile Ducts; Dimethylnitrosamine; Diosgenin; Dose-Response Relationship, Drug; Hepatic Stellate Cells; Humans; Ligation; Liver Cirrhosis; Male; MAP Kinase Signaling System; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sirtuin 1

2016